Form 4 for CHRS Coherus Oncology, Inc.
Accepted 2026-01-22 00:00:00 ET · period of report 2026-01-20 · accession 0001610717-26-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-22 | 2026-01-20 | CHRS | McMichael Bryan J | CFO | F - Tax | $1.55 | -1,715 | 21.2K | -7% | -$2,658 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | F | D | 1,715 | $1.55 | 21,236 | D | — | — | (F1) Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction. |